This exploration compound was very first described by Hoffman-La Roche in 2009. It’s among various benzodiazepines from the imidazobenzodiazepine subgroup believed to offer nootropic benefits.This compound is taken into account an intermediate-performing hypnotic with a very quick onset of consequences. The consequences of nimetazepam can be felt… Read More